1 | vital health pharmaceuticals inc | | | | | | | 3 | 0.96% |
2 | to restore support andor | | | | | | | 2 | 0.64% |
3 | restore support andor improve | | | | | | | 2 | 0.64% |
4 | support andor improve health | | | | | | | 2 | 0.64% |
5 | andor improve health and | | | | | | | 2 | 0.64% |
6 | our wide and evolving | | | | | | | 2 | 0.64% |
7 | toggle navigation vital health | | | | | | | 1 | 0.32% |
8 | nutritional supplements industry includes | | | | | | | 1 | 0.32% |
9 | the nutritional supplements industry | | | | | | | 1 | 0.32% |
10 | product tested products str | | | | | | | 1 | 0.32% |
11 | in the nutritional supplements | | | | | | | 1 | 0.32% |
12 | a product tested products | | | | | | | 1 | 0.32% |
13 | impact a product tested | | | | | | | 1 | 0.32% |
14 | can impact a product | | | | | | | 1 | 0.32% |
15 | that can impact a | | | | | | | 1 | 0.32% |
16 | factors that can impact | | | | | | | 1 | 0.32% |
17 | all factors that can | | | | | | | 1 | 0.32% |
18 | supplements industry includes laboratory | | | | | | | 1 | 0.32% |
19 | industry includes laboratory testing | | | | | | | 1 | 0.32% |
20 | includes laboratory testing to | | | | | | | 1 | 0.32% |
21 | fda gmps for potency | | | | | | | 1 | 0.32% |
22 | a lot more in | | | | | | | 1 | 0.32% |
23 | have a lot more | | | | | | | 1 | 0.32% |
24 | we have a lot | | | | | | | 1 | 0.32% |
25 | potency we have a | | | | | | | 1 | 0.32% |
26 | for potency we have | | | | | | | 1 | 0.32% |
27 | gmps for potency we | | | | | | | 1 | 0.32% |
28 | pharmacopeia usp and the | | | | | | | 1 | 0.32% |
29 | ensure compliance to dshea | | | | | | | 1 | 0.32% |
30 | states pharmacopeia usp and | | | | | | | 1 | 0.32% |
31 | united states pharmacopeia usp | | | | | | | 1 | 0.32% |
32 | the united states pharmacopeia | | | | | | | 1 | 0.32% |
33 | dshea the united states | | | | | | | 1 | 0.32% |
34 | to dshea the united | | | | | | | 1 | 0.32% |
35 | compliance to dshea the | | | | | | | 1 | 0.32% |
36 | of all factors that | | | | | | | 1 | 0.32% |
37 | follows an approved set | | | | | | | 1 | 0.32% |
38 | sops of all factors | | | | | | | 1 | 0.32% |
39 | navigation vital health home | | | | | | | 1 | 0.32% |
40 | control expected from a | | | | | | | 1 | 0.32% |